MoneyWorks4Me

The Revenue for the quarter ended  March 2024 of Rs. 14745.50 millions grew by 12.81 % from Rs. 13071.20 millions.Handsome Net Profit growth of 54.64% reported above the corresponding previous quarter figure of Rs. 2018.70 millions to Rs. 1305.40 millions.Operating Profit saw a handsome growth to 2954.20 millions from 1711.40 millions in the quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 14745.50 13071.20 12.81 58740.60 51490.00 14.08 58740.60 51490.00 14.08
Other Income 72.30 19.60 268.88 313.20 35.40 784.75 313.20 35.40 784.75
PBIDT 2954.20 1711.40 72.62 10298.40 6678.80 54.20 10298.40 6678.80 54.20
Interest 101.30 135.90 -25.46 544.70 490.00 11.16 544.70 490.00 11.16
PBDT 2852.90 1575.50 81.08 9753.70 6188.80 57.60 9753.70 6188.80 57.60
Depreciation 691.20 735.40 -6.01 2711.40 2729.50 -0.66 2711.40 2729.50 -0.66
PBT 2161.70 840.10 157.31 7042.30 3459.30 103.58 7042.30 3459.30 103.58
TAX 143.00 -465.30 -130.73 377.50 -8.00 -4818.75 377.50 -8.00 -4818.75
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 2018.70 1305.40 54.64 6664.80 3467.30 92.22 6664.80 3467.30 92.22
Equity 393.10 393.10 0.00 393.10 393.10 0.00 393.10 393.10 0.00
PBIDTM(%) 20.03 13.09 53.02 17.53 12.97 35.16 17.53 12.97 35.16
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..